Alain Huriez
Chief Executive Officer
Alain Huriez MD, is since mid 2006 Chairman and Chief Executive Officer of TcLand Expression. Alain is one the company’s co-founders. From early 2003 to mid 2006 Alain was CEO at Neovacs SA, a company developing therapeutic vaccines.
Alain brings an experience of general management and financing in the biotechnology sector, in various executive positions as Associate Partner Biotech at Truffle Capital, a €220m VC fund (2002-2003), Vice-President Quintiles Europe, the world's largest CRO (1999-2002), in charge of the Biotechnology Consulting Group, a separate entity that he founded, specialized in offering strategic counsel to biotechnology listed companies in Europe and the USA. As Vice President of the Biotechnology Consulting Group, Alain set up EU subsidiaries for TSE/NASDAQ listed biotechnology companies. Alain brings also fifteen years of experience in biotech drug development, from pre-clinical to registration in several executive positions both in the pharmaceutical (GSK) and in the service industry (MDS, Innovex, Quintiles).
Alain is Medical Doctor, holds a Post Graduate degree in Business Administration (MBA), a Statistics degree from the University of Paris VII, and a Masters of Pharmaco-Economics from the University of Paris I Sorbonne.
Prior to joining the Pharmaceutical Industry, he worked 1 year as head of an emergency room in a large teaching hospital and practiced 2 years as General Practitioner. Alain supports and triggers several biotechnology initiatives in France, is Vice President of LEEM Biotech.